33 Special Types of Invasive Breast Carcinoma: Diagnostic Criteria ...
33 Special Types of Invasive Breast Carcinoma: Diagnostic Criteria ...
33 Special Types of Invasive Breast Carcinoma: Diagnostic Criteria ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Because more than half <strong>of</strong> adenoid cystic carcinomas are infiltrative focally, the most<br />
important therapeutic goal is complete tumor removal with uninvolved margins <strong>of</strong><br />
excision.<br />
Pastolero et al. (27) have recently studied proliferative activity and p53 expression in<br />
four cases <strong>of</strong> adenoid carcinoma <strong>of</strong> the breast. The pathologic features examined<br />
included light microscopy; electron microscopy; immunohistochemistry using<br />
antibodies to keratin, vimentin, S100 protein, actin, estrogen, and progesterone<br />
receptors, and proliferation marker MiB-1, and p53 suppressor protein; image<br />
cytometric analysis for measurement <strong>of</strong> DNA ploidy; and molecular analysis using<br />
polymerase chain reaction single strand conformation polymorphism to assess point<br />
mutation <strong>of</strong> the p53 gene. All <strong>of</strong> the cases had a low nuclear grade, were negative for<br />
estrogen and progesterone receptors, and were DNA diploid. Three <strong>of</strong> the cases<br />
showed no evidence <strong>of</strong> metastases and had<br />
small primary tumors with low proliferative activity and absence <strong>of</strong> p53 protein<br />
expression. In contrast, one <strong>of</strong> the cases showed axillary lymph node metastases and in<br />
this case the primary tumor was large with a higher proliferative activity and<br />
expression <strong>of</strong> p53 protein, suggesting that these factors might play a role in the<br />
biological behavior <strong>of</strong> adenoid cystic carcinoma. These data suggest that detailed<br />
molecular analysis may identify a group <strong>of</strong> aggressive adenoid cystic carcinomas. We<br />
have recently studied adenoid cystic carcinomas <strong>of</strong> salivary glands and showed<br />
relatively high MIB-1 staining and frequently strong expression <strong>of</strong> Bcl-2, the<br />
apoptosis suppressor protein (28).<br />
Some conventional, less favorable forms <strong>of</strong> mammary carcinoma may be incorrectly<br />
diagnosed as adenoid cystic carcinoma (1, 2, 13); ~50% <strong>of</strong> the cases <strong>of</strong> adenoid cystic<br />
breast carcinoma recorded by the Connecticut Tumor Registry were misclassified<br />
(13). Most <strong>of</strong> the errors resulted from including invasive duct and even multifocal<br />
intraductal carcinomas with a prominent cribriform component. Problems also occur<br />
in distinguishing adenoid cystic from papillary and mucinous carcinomas.<br />
Differential diagnosis: Although many varieties <strong>of</strong> cutaneous adnexal tumors can<br />
arise in the skin and subcutis overlying the breast, some <strong>of</strong> these lesions deserve<br />
special mention because <strong>of</strong> their propensity for occurring within the breast (29-40).<br />
These are the infiltrating syringomatous adenoma <strong>of</strong> the nipple and mixed<br />
salivary-type (pleomorphic) adenoma <strong>of</strong> the breast (29-38). Given the common<br />
embryologic origin <strong>of</strong> the sweat, salivary, and mammary glands, finding similar<br />
72